Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Oncology and Therapy is Scopus-indexed (Q2, CiteScore 4.4), WoS ESCI, DOAJ. Published by Adis.
Checked against the index lists dated .
ISSN 2366-1070Verify ISSN ↗2366-1089Verify ISSN ↗
Publisher: Adis
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 195 / 428 | 54th | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2018–present (also 2016), best quartile Q2, CiteScore 4.4.
Oncology and Therapy is Q2 in Oncology (rank 195 of 428), by CiteScore 2025.
Oncology and Therapy is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.4, which places it in quartile Q2 at the 54th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.159, quartile Q2, with an H-index of 24.
The publisher lists an article processing charge of about US$7,400 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Oncology and Therapy is published by Adis. Its print ISSN is 2366-1070 and its online ISSN is 2366-1089.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Oncology and Therapy has an h-index of 33 and a 2-year mean of 2.47 citations per paper (OpenAlex). Its Scopus CiteScore is 4.4, quartile Q2. On 2-year citations it ranks #152 of 424 Scopus journals in Oncology.
Oncology and Therapy published 88 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2025–2026), authors are most often from United States (32.2%), United Kingdom (11.7%) and Italy (8.5%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 1 retracted paper is recorded (2.4 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.